IntoCell, Inc. (KOSDAQ: A287840)
Health Care · Biotechnology · KR
₩17,320.00
-4.04% today · -57.0% 1Y
IntoCell, Inc. (KOSDAQ: A287840) operates in the Biotechnology industry within the Health Care sector. The company is valued at $193.53M.
Over the last twelve months the share price has lost 57.0%, trading between 13.05K and 74.90K.
Tweenvest scores IntoCell, Inc. across four factors: quality 39/100, value 48/100. Its strongest factor is value.
A287840 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $193.53M
- Revenue (TTM)
- $2.06M
- P/E
- —
- EPS
- -632.06
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩74,900.00
- 52-week low
- ₩13,050.00
- Avg volume (3M)
- —
- Shares outstanding
- 15.02M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| S.Biomedics Co., Ltd.KOSDAQ: A304360 | $200.37M | ₩21,750.00 | +4.07% |
| Exagen Inc.NasdaqGM: XGN | $199.86M | $8.25 | -2.02% |
| Alpha Cognition Inc.NasdaqCM: ACOG | $196.87M | $8.84 | -2.21% |
| Thor Medical ASAOB: TRMED | $196.75M | Nkr4.46 | -1.00% |
| Adagene Inc.NasdaqGM: ADAG | $185.32M | $2.74 | -0.72% |
| Precision BioSciences, Inc.NasdaqCM: DTIL | $180.24M | $6.53 | -2.83% |
| Hester Biosciences LimitedBSE: 524669 | $179.48M | Rs2,041.90 | -4.61% |
| Compass Therapeutics, Inc.NasdaqCM: CMPX | $178.83M | $0.94 | -5.59% |
Figures last refreshed Oct 11, 2026.